Related Experiment Video
Updated: Aug 8, 2026
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
IL-1 alpha antiproliferative and differentiative effects on Daudi lymphoma cells: multiparametric analysis
E Santavenere1, R Di Pietro, M A Centurione
1Istituto di Morfologia Umana Normale, Chieti, Italy.
Insights
Interleukin I alpha (IL-1) affects Daudi lymphoma cells by reducing proliferation and arresting the cell cycle. This potent cytokine also induces cell differentiation, evidenced by increased Fc receptor expression.
Area of Science:
- Immunology
- Cell Biology
- Oncology
Background:
- Interleukin I alpha (IL-1) is a cytokine with diverse biological activities.
- Daudi lymphoma cells represent a unique cell line for studying cytokine-induced effects.
Purpose of the Study:
- To investigate the impact of Interleukin I alpha (IL-1) on the cell cycle progression of Daudi lymphoma cells.
- To evaluate the potential of IL-1 to induce differentiation in Daudi lymphoma cells.
Main Methods:
- Cell cycle analysis using light microscopy and anti-BrdU monoclonal antibodies.
- Quantification of DNA synthesis via [3H]-thymidine incorporation.
- Assessment of cell differentiation through Fc receptor expression and morphological changes.
Main Results:
- IL-1 treatment led to a reduced proliferation rate, characterized by G1 phase arrest.
- Decreased [3H]-thymidine incorporation indicated a lower rate of DNA synthesis.
- A significant increase in Fc receptor expression and observable morphological changes indicated induced differentiation after 24 hours.
Conclusions:
- Interleukin I alpha (IL-1) effectively inhibits proliferation and induces G1 arrest in Daudi lymphoma cells.
- IL-1 promotes differentiation in Daudi lymphoma cells.
- Daudi lymphoma cells exhibit sensitivity to IL-1, demonstrating multiparametric responses to this cytokine.
Abstract:
Interleukin I alpha (IL-1) is a potent agent that induces a wide range of biological effects. In this study we analysed its effects on cell cycle progression and differentiation of Daudi lymphoma cells. The parallel analysis in light microscopy and cytofluorimetry by means of anti-BrdU monoclonal antibodies showed a reduced rate of proliferation (S phase) with a G1 arrest. These features were confirmed by the lower incorporation of [3H]-thymidine supporting the decrease in the rate of DNA synthesis. In addition this cytokine was able to induce differentiation after 24 hrs of treatment as assessed by the increased expression of Fc receptors (FcR) and morphological criteria. This multiparametric analysis gives evidence to the sensitivity to this cytokine of this peculiar cell line.
